These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10717235)

  • 21. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
    Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
    Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NRG1 fusions in breast cancer.
    Howarth KD; Mirza T; Cooke SL; Chin SF; Pole JC; Turro E; Eldridge MD; Garcia RM; Rueda OM; Boursnell C; Abraham JE; Caldas C; Edwards PAW
    Breast Cancer Res; 2021 Jan; 23(1):3. PubMed ID: 33413557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.
    Seraj MJ; Samant RS; Verderame MF; Welch DR
    Cancer Res; 2000 Jun; 60(11):2764-9. PubMed ID: 10850410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.
    Courjal F; Cuny M; Simony-Lafontaine J; Louason G; Speiser P; Zeillinger R; Rodriguez C; Theillet C
    Cancer Res; 1997 Oct; 57(19):4360-7. PubMed ID: 9331099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPFIA1 and CCND1 are frequently coamplified in breast cancer.
    Dancau AM; Wuth L; Waschow M; Holst F; Krohn A; Choschzick M; Terracciano L; Politis S; Kurtz S; Lebeau A; Friedrichs K; Wencke K; Monni O; Simon R
    Genes Chromosomes Cancer; 2010 Jan; 49(1):1-8. PubMed ID: 19787783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.
    Chua YL; Ito Y; Pole JC; Newman S; Chin SF; Stein RC; Ellis IO; Caldas C; O'Hare MJ; Murrell A; Edwards PA
    Oncogene; 2009 Nov; 28(46):4041-52. PubMed ID: 19802002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers.
    Theillet C; Adelaide J; Louason G; Bonnet-Dorion F; Jacquemier J; Adnane J; Longy M; Katsaros D; Sismondi P; Gaudray P
    Genes Chromosomes Cancer; 1993 Aug; 7(4):219-26. PubMed ID: 7692948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.
    Huang HE; Chin SF; Ginestier C; Bardou VJ; Adélaïde J; Iyer NG; Garcia MJ; Pole JC; Callagy GM; Hewitt SM; Gullick WJ; Jacquemier J; Caldas C; Chaffanet M; Birnbaum D; Edwards PA
    Cancer Res; 2004 Oct; 64(19):6840-4. PubMed ID: 15466169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer.
    Rosa-Rosa JM; Pita G; González-Neira A; Milne RL; Fernandez V; Ruivenkamp C; van Asperen CJ; Devilee P; Benitez J
    Breast Cancer Res Treat; 2009 Nov; 118(1):151-9. PubMed ID: 19205878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridization.
    Xie D; Jauch A; Miller CW; Bartram CR; Koeffler HP
    Int J Oncol; 2002 Sep; 21(3):499-507. PubMed ID: 12168092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predisposition for breast cancer in carriers of constitutional translocation 11q;22q.
    Lindblom A; Sandelin K; Iselius L; Dumanski J; White I; Nordenskjöld M; Larsson C
    Am J Hum Genet; 1994 May; 54(5):871-6. PubMed ID: 8178827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q.
    Jin Y; Höglund M; Jin C; Martins C; Wennerberg J; Akervall J; Mandahl N; Mitelman F; Mertens F
    Genes Chromosomes Cancer; 1998 Aug; 22(4):312-20. PubMed ID: 9669669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Heregulin gene can be included in the 8p12 amplification unit in human breast cancer.
    Adélaïde J; Penault-Llorca F; Dib A; Yarden Y; Jacquemier J; Birnbaum D
    Genes Chromosomes Cancer; 1994 Sep; 11(1):66-9. PubMed ID: 7529049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
    Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
    Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
    Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
    Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma.
    Bekri S; Adélaïde J; Merscher S; Grosgeorge J; Caroli-Bosc F; Perucca-Lostanlen D; Kelley PM; Pébusque MJ; Theillet C; Birnbaum D; Gaudray P
    Cytogenet Cell Genet; 1997; 79(1-2):125-31. PubMed ID: 9533029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of chromosome 8p sequences in human breast carcinoma cell lines.
    Pykett MJ; Murphy ME; Harnish PR; Muenke M; Marks J; George DL
    Cancer Genet Cytogenet; 1994 Aug; 76(1):23-8. PubMed ID: 8076345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.
    Wagner U; Bubendorf L; Gasser TC; Moch H; Görög JP; Richter J; Mihatsch MJ; Waldman FM; Sauter G
    Am J Pathol; 1997 Sep; 151(3):753-9. PubMed ID: 9284824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma.
    Huang X; Godfrey TE; Gooding WE; McCarty KS; Gollin SM
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1058-69. PubMed ID: 16906560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.